Mintz has again been recognized as one of the most active and high-performing law firms for patent prosecution in Patexia’s LexDana 2026 Patent Prosecution Intelligence Report, reflecting the depth and breadth of the firm’s patent prosecution practice across biotechnology, high‑tech, and other innovation‑driven technologies.

In the report, Mintz ranked among the top 25 law firms in biotechnology based on patent prosecution activity and performance, earning recognition as the 12th most active and 15th best performing firm in the biotech space. Mintz also received recognition in Patexia’s high‑tech patent prosecution rankings for both activity and performance.

In addition, the firm ranked among the top 100 law firms overall, based on Patexia’s assessment of patent prosecution activity and performance across all technologies and industries.

Several Mintz attorneys and patent agents were also individually recognized for their contributions to biotech patent prosecution in the report:

•    Jenny Chen, PhD, recognized for patent prosecution activity and performance
•    Trudy Rey, PhD, recognized for performance in patent prosecution
•    Edward Grieff, recognized for activity in patent prosecution
•    Edmund Koundakjian, recognized for performance in patent prosecution

Patexia’s rankings assess patent prosecution activity and performance before the US Patent and Trademark Office over a five‑year period, evaluating factors such as outcomes, consistency across filings, filing volume, and sustained engagement across clients and technologies. The full list of rankings can be found here.